Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.
Wai Chun Bio-Technology Limited has appointed Ms. He Xiaoping as company secretary and authorised representative with effect from 5 March 2026, following the resignation of Ms. Chin Ying Ying from these roles in December 2024. The move ensures continuity in the company’s compliance and corporate governance functions under Hong Kong Listing Rules.
Ms. He brings more than 13 years of experience in auditing, financial management, company secretarial work, investment and financing, having worked at leading accounting firms and various Hong Kong-listed companies. The board believes her professional background, including membership in the Hong Kong Institute of Certified Public Accountants, positions her to effectively discharge the responsibilities of these key regulatory and governance posts.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded on the Main Board of the Stock Exchange of Hong Kong. The group operates in the bio-technology and related sectors, with its governance overseen by a board comprising one executive director and three independent non-executive directors.
Average Trading Volume: 152,766
Technical Sentiment Signal: Buy
Current Market Cap: HK$46.4M
See more data about 0660 stock on TipRanks’ Stock Analysis page.